Journal
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume 99, Issue 4, Pages 702-711Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09553002.2022.2110304
Keywords
Ionizing radiation; circulatory effects; cardiovascular diseases; Million Person Study; radiation workers; Canadian fluoroscopy cohort study
Ask authors/readers for more resources
This article summarizes presentations from a session on Radiation and Circulatory Effects at the Radiation Research Society Online 67(th) Annual Meeting. The talks showed that low/moderate doses of radiation can be associated with an increased risk of cardiovascular disease. However, there is uncertainty in the epidemiological results.
Purpose This article summarizes a number of presentations from a session on Radiation and Circulatory Effects held during the Radiation Research Society Online 67(th) Annual Meeting, October 3-6 2021. Materials and Methods Different epidemiological cohorts were analyzed with various statistical means common in epidemiology. The cohorts included the one from the U.S. Million Person Study and the Canadian Fluoroscopy Cohort Study. In addition, one of the contributions in our article relies on results from analyses of the Japanese atomic bomb survivors, Russian emergency and recovery workers and cohorts of nuclear workers. The Canadian Fluoroscopy Cohort Study data were analyzed with a larger series of linear and nonlinear dose-response models in addition to the linear no-threshold (LNT) model. Results and Conclusions The talks in this symposium showed that low/moderate acute doses at low/moderate dose rates can be associated with an increased risk of CVD, although some of the epidemiological results for occupational cohorts are equivocal. The usually only limited availability of information on well-known risk factors for circulatory disease (e.g. smoking, obesity, hypertension, diabetes, physical activity) is an important limiting factor that may bias any observed association between radiation exposure and detrimental health outcome, especially at low doses. Additional follow-up and careful dosimetric and outcome assessment are necessary and more epidemiological and experimental research is required. Obtaining reliable information on other risk factors is especially important.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available